Overview
Lauri is an experienced healthcare regulatory and transactional attorney, with a special focus on all legal matters related to clinical research, including representation of pharmaceutical companies and clinical sites.
Lauri joined Benesch in 2019 and has been involved in numerous health care transactions and acquisitions, including hospital acquisitions by non-profit health systems, corporate life sciences and private equity, nephrology dialysis joint ventures, and physician practice acquisitions, paying particular attention to the corporate practice of medicine and fee splitting prohibitions. As a result of her broad expertise, Lauri has developed a nationwide practice involving regulatory matters and compliance/HIPAA, health care fraud and abuse, medical staff bylaws and credentialing issues, hospital system contracts including material electronic medical record agreements, and physician practice group matters. Lauri has advised clients and written extensively on telehealth/telemedicine under the regulatory environment, in particular during the COVID pandemic, and is part of the nationally recognized Benesch Cannabis Industry Group.
Prior to joining Benesch, for over 20 years, Lauri served as vice president and general counsel for a state academic medical center and also in-house for a large integrated health care system that was involved in acquiring numerous hospitals. For the state institution, as also serving as Assistant Attorney General for the State of Ohio, Lauri advised on public law matters such as sunshine laws and state immunity, providing confidential health care advice to state boards, executive teams and a faculty practice plan that included over 260 physicians of various specialties. In addition to being instrumental in the merging of two large state institutions, Lauri was involved in the creation of a state funded institutional self-insurance captive.
Experience
Represented one of the largest inpatient psych hospital chains in the U.S. against nine EMTALA (Emergency Medical Treatment and Labor Act) violations brought by the Centers for Medicare and Medicaid (CMS) and referred to the U.S. Office of Inspector General (OIG). The allegations against the client were the result of a surprise onsite EMTALA audit by CMS. The Benesch team prepared and represented the client through the due process hearing held in front of a panel of QIO physicians. Upon review of the hearing materials, the OIG decided not to pursue civil money penalties against the client which could have exceeded $111,000 per violation.
Represented Petauri, a portfolio company of Oak Hill Capital, in its acquisition of Formulary Insights, a market access services provider in the pharmaceutical and life sciences industry.
Represented a private equity sponsored buyer in its acquisition of a provider of medical communications, marketing and education services.
Represented IntegriChain, a portfolio company of Nordic Capital, in its acquisition of BridgeView Data Solutions, a commercial data warehouse and data aggregation business.
Represents pharmaceutical institutional sites and consultants in all areas of clinical research.
Represented State University faculty practice plan in this development of an ASC.
Represented private equity in life science service acquisitions.
Represented Lighthouse Behavioral Health Solutions in its recapitalization by Amulet Capital Partners, a private equity firm.
Represented multiple health care providers in nephrology and dialysis facility joint ventures.
Represent management support organization supplying management services to physician practices in New York, New Jersey and other states with a focus on physician extenders, physiatry, telemedicine and remote patient monitoring so as to enhance EBITDA for future capital event. Handled all aspects of structuring, diligence and execution of all arrangements. Advised on post-closing integration and provide ongoing regulatory support.
Represented Continuing Healthcare Solutions in participation in an Ohio specific joint venture to develop a Medicare Advantage Plan.
Representation of Bellwether Behavioral Health, a large national provider of services to developmentally disabled individuals, in connection with the appointment of a receiver and the winddown of the company.
Counseled multi-specialty providers with respect to corporate practice of medicine, fee splitting and other health care regulatory concerns.
Represented nephrology providers in research compliance, transactional joint ventures and other regulatory challenges.
Advised multiple health care provider clients with compliance and policy development in telehealth during the COVID-19 National Public Emergency.
Advised the Medical University of Ohio during its merger with the University of Toledo, creating the third-largest public university operating budget in the state of Ohio.*
*Prior to joining Benesch
No results found
Credentials
Education
Clerkships and Bar Admissions
More
- Member, American Health Lawyers Association
- ACLU Liaison, Voter Registration Project
Related News & Insights
Nesko Radovic, Scott Downing and Lauri Cooper Published in RPA News | “CMS’s IOTA Model Took Effect July 1, 2025: Implications For Transplant Hospitals and Nephrology Stakeholders”
CMS’s IOTA Model Took Effect July 1, 2025: Implications for Transplant Hospitals and Nephrology Stakeholders
Key Takeaways: On July 1, 2025, CMS launched the mandatory Increasing Organ Transplant Access (IOTA) Model, requiring about 100 randomly …
OCR Proposes Modification to HIPAA Security Rule
In late December 2024, the Office of Civil Rights at the U.S. Department of Health and Human Services (“OCR”) issued …
New Final Rules for Telemedicine Prescribing: Extending Telemedicine Flexibilities and What Substance Use Disorder (SUD) Treatment Providers Need to Know
The Drug Enforcement Administration (DEA), together with the U.S. Department of Health and Human Services (HHS) published two final rules …